# OnCo record paper-malla-ctdna-resected-biliary-tract-cancer-esmo-gi-onc-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-malla-ctdna-resected-biliary-tract-cancer-esmo-gi-onc-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-malla-ctdna-resected-biliary-tract-cancer-esmo-gi-onc-2026" ;
  schema:name "Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer"@en ;
  schema:description "In 167 people whose bile duct or gallbladder cancer had been removed, a blood test for tumour DNA in the weeks after surgery picked out those whose cancer would return far better than the standard blood markers."@en ;
  schema:url <https://onco.cc/key-papers/paper-malla-ctdna-resected-biliary-tract-cancer-esmo-gi-onc-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.esmogo.2026.100344>, <https://pubmed.ncbi.nlm.nih.gov/42583118/> ;
  onco:tag "gallbladder-evidence" ;
  schema:sameAs <https://doi.org/10.1016/j.esmogo.2026.100344> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Malla M, Esmail A, Tin A, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/signatera/> ;
  onco:companies <https://onco.cc/companies/natera/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ca19-9/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/> .